Resolute Mining Limited released June Quarterly Activities Report

istock  small

June Quarterly Activities Report: Resolute Mining Limited’s (ASX: RSG) stock fell 0.613% on July 24, 2018 after the company released June Quarterly Activities Report. The company during the June 2018 quarter has 75,000 ounces of gold at an AISC of A$1,303/oz (US$986/oz). In FY 18, the gold production is of 284koz at AISC of A$1,355/oz (US$1,051/oz), which is ahead of the revised guidance of 280koz at A$1,360/oz.  Further, Syama Underground mine development is on track and is due for project completion and commencement of full sub-level caving in December 2018, with ramp up to occur in 2019. Syama DFS Update showed materially lower costs (LOM AISC of US$746/oz) and extension of mine life to 2032. Moreover, the update on Ravenswood Expansion Project reflects an optimised mining and processing schedule, a revised processing and tailings management strategy, and the incorporation of new technologies to improve efficiency. Ravenswood will now, on average, produce approximately 115,000 ounces annually at a Life of Mine All-In Sustaining Cost of A$1,097 per ounce (US$823 per ounce) through to 2032. The company has received Bibiani Environmental Permit Authorisation and the operational readiness phase will commence in FY19. Additionally, RSG has made strategic investment in TSX-listed, Sudan-focused developer, Orca Gold Inc. The company has received an average gold price of A$1,703/oz (US$1,320/oz) from total FY18 gold sales of 262,381oz. RSG’s cash, bullion and listed investments as at 30 June 2018 is of A$113m (US$84m). In addition, in first half of FY 19, the development of the Syama Underground will continue, which will provide an increasing contribution to sulphide processing from high grade development ore. In the current quarter, the development and production of ore from the Tabakaroni satellite operation will commence. Meanwhile, RSG stock has fallen 1.14% in three months as on July 23, 2018  and is trading at a P/E of 8.40x.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report